Percutaneous ultrasound-guided radiofrequency ablation of hepatocellular carcinoma with artificially induced pleural effusion and ascites
Authors:
- 26 April 2007
- journal article
- Published by Springer Nature in Journal of Gastroenterology
- Vol. 42 (4) , 306-311
Abstract
Ultrasound-guided procedures are sometimes of limited use because the tumor is located under the diaphragm or near the surface of the liver. We investigated the safety and efficacy of radiofrequency ablation (RFA) with artificial pleural effusion and/or artificial ascites. Between January 2002 and May 2006, 43 lesions in 36 patients with hepatocellular carcinoma (HCC) were treated by RFA with artificial pleural effusion and/or artificial ascites. Artificial pleural effusion allowed visualization of the whole tumor for 36 (83.7%) of the 43 lesions that were otherwise not detectable or poorly visible. Artificial ascites was also helpful in visualizing whole tumors that could not be visualized with only artificial pleural effusion. In all lesions, artificial pleural effusion and/or artificial ascites were helpful in performing percutaneous RFA. Artificial ascites was useful for creating a space between the liver's surface and the skin or diaphragm to avoid burns. Adverse effects after the induction of artificial pleural effusion included pneumonia in one patient and temporary atelectasis in another patient. Severe side effects were not observed. Complete necrosis after RFA was obtained in 43 (100%) of the 43 lesions. During a mean follow-up period of 31.8 ± 5.8 months, local recurrence at the ablation site was found in none of the 43 lesions. Percutaneous RFA with artificial pleural effusion and/or artificial ascites was a safe and useful treatment that resulted in good local control of HCC.Keywords
This publication has 21 references indexed in Scilit:
- Artificial ascites technique for percutaneous radiofrequency ablation of liver cancer adjacent to the gastrointestinal tractBritish Journal of Surgery, 2006
- Radiofrequency ablation for hepatocellular carcinoma in so-called high-risk locationsHepatology, 2006
- Percutaneous radiofrequency ablation for hepatocellular carcinomaCancer, 2005
- Abdominal virtual ultrasonographic images reconstructed by multi-detector row helical computed tomographyEuropean Journal of Radiology, 2005
- Percutaneous Sonographically Guided Radiofrequency Ablation with Artificial Pleural Effusion for Hepatocellular Carcinoma Located Under the DiaphragmAmerican Journal of Roentgenology, 2004
- Risk factors for the local recurrence of hepatocellular carcinoma after a single session of percutaneous radiofrequency ablationJournal of Gastroenterology, 2003
- Risk factors for local recurrence of small hepatocellular carcinoma tumors after a single session, single application of percutaneous radiofrequency ablationCancer, 2003
- Thoracoscopic Thermal Ablation Therapy for Hepatocellular Carcinoma Located Beneath the DiaphragmEndoscopy, 2001
- Percutaneous Microwave Coagulation Therapy Using Artificial AscitesAmerican Journal of Roentgenology, 2001
- Percutaneous RF interstitial thermal ablation in the treatment of hepatic cancer.American Journal of Roentgenology, 1996